193 related articles for article (PubMed ID: 22352922)
1. Quantitative and site-directed chemical modification of hypocrellins toward direct drug delivery and effective photodynamic activity.
Deng H; Liu X; Xie J; Yin R; Huang N; Gu Y; Zhao J
J Med Chem; 2012 Mar; 55(5):1910-9. PubMed ID: 22352922
[TBL] [Abstract][Full Text] [Related]
2. Synthesis, characterization and photodynamic activity of amino-substituted hypocrellin derivatives.
Tang YJ; Liu HY; An JY; Han R
Photochem Photobiol; 2001 Aug; 74(2):201-5. PubMed ID: 11547555
[TBL] [Abstract][Full Text] [Related]
3. A novel elsinochrome A derivative: a study of drug delivery and photodynamic activity.
Zhang Y; Xie J; Zhang L; Li C; Chen H; Gu Y; Zhao J
Photochem Photobiol Sci; 2009 Dec; 8(12):1676-82. PubMed ID: 20024164
[TBL] [Abstract][Full Text] [Related]
4. A novel hypocrellin B derivative designed and synthesized by taking consideration to both drug delivery and biological photodynamic activity.
Liu X; Xie J; Zhang L; Chen H; Gu Y; Zhao J
J Photochem Photobiol B; 2009 Mar; 94(3):171-8. PubMed ID: 19131255
[TBL] [Abstract][Full Text] [Related]
5. Oxovanadium(IV) based hypocrellin B complexes with enhanced photodynamic activity.
Sun Y; Zheng Y; Lei WH; Zhou QX; Hou YJ; Zhang BW; Wang XS
Dalton Trans; 2012 Jan; 41(2):651-7. PubMed ID: 22068883
[TBL] [Abstract][Full Text] [Related]
6. New potential photodynamic therapeutic anti-cancer agents: synthesis and characterization of demethoxy amino-substituted hypocrellins.
Wu T; Xu S; Shen J; Song A; Chen S; Zhang M; Shen T
Anticancer Drug Des; 2000 Aug; 15(4):287-93. PubMed ID: 11200504
[TBL] [Abstract][Full Text] [Related]
7. In vitro and in vivo antitumor activity of a novel hypocrellin B derivative for photodynamic therapy.
Zhao H; Yin R; Chen D; Ren J; Wang Y; Zhanga J; Deng H; Wang Y; Qiu H; Huang N; Zou Q; Zhao J; Gu Y
Photodiagnosis Photodyn Ther; 2014 Jun; 11(2):204-12. PubMed ID: 24534694
[TBL] [Abstract][Full Text] [Related]
8. Biophysical evaluation of two red-shifted hypocrellin B derivatives as novel PDT agents.
Paul BT; Babu MS; Santhoshkumar TR; Karunagaran D; Selvam GS; Brown K; Woo T; Sharma S; Naicker S; Murugesan R
J Photochem Photobiol B; 2009 Jan; 94(1):38-44. PubMed ID: 18977666
[TBL] [Abstract][Full Text] [Related]
9. Synthesis, characterization and photodynamic activity of phenmethylamino-demethoxy-hypocrellin B.
Xu S; Chen S; Zhang M; Shen T
J Photochem Photobiol B; 2003 Dec; 72(1-3):61-7. PubMed ID: 14644567
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and characterization of the monomer ruthenium complex of hypocrellin B.
Zhou J; Liu J; Feng Y; Wei S; Gu X; Wang X; Zhang B
Bioorg Med Chem Lett; 2005 Jun; 15(12):3067-70. PubMed ID: 15913997
[TBL] [Abstract][Full Text] [Related]
11. Hypocrellins as photosensitizers for photodynamic therapy: a screening evaluation and pharmacokinetic study.
Estey EP; Brown K; Diwu Z; Liu J; Lown JW; Miller GG; Moore RB; Tulip J; McPhee MS
Cancer Chemother Pharmacol; 1996; 37(4):343-50. PubMed ID: 8548880
[TBL] [Abstract][Full Text] [Related]
12. Near-Infrared Hypocrellin Derivatives for Synergistic Photodynamic and Photothermal Therapy.
Ding Y; Liu W; Wu J; Zheng X; Ge J; Ren H; Zhang W; Lee CS; Wang P
Chem Asian J; 2020 Nov; 15(21):3462-3468. PubMed ID: 32909355
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and characterization of three novel amphiphilic aminated hypocrellins as photodynamic therapeutic agents.
Xu S; Chen S; Zhang M; Shen T; Zhang X; Wang Z
Photochem Photobiol; 2003 Oct; 78(4):411-5. PubMed ID: 14626671
[TBL] [Abstract][Full Text] [Related]
14. Novel surfactant-like hypocrellin derivatives to achieve simultaneous drug delivery in blood plasma and cell uptake.
Zhang Y; Song L; Xie J; Qiu H; Gu Y; Zhao J
Photochem Photobiol; 2010; 86(3):667-72. PubMed ID: 20331522
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and EPR investigations of new aminated hypocrellin derivatives.
He YY; Jiang LJ
Free Radic Biol Med; 2000 Jun; 28(11):1642-51. PubMed ID: 10938461
[TBL] [Abstract][Full Text] [Related]
16. Ultrasound-Enhanced Self-Exciting Photodynamic Therapy Based on Hypocrellin B.
Ding Y; Liu W; Wu J; Zheng X; Ge J; Ren H; Zhang W; Lee CS; Wang P
Chem Asian J; 2021 May; 16(10):1221-1224. PubMed ID: 33881805
[TBL] [Abstract][Full Text] [Related]
17. Hypocrellin B-encapsulated nanoparticle-mediated rev-caspase-3 gene transfection and photodynamic therapy on tumor cells.
Bai D; Xia X; Yow CM; Chu ES; Xu C
Eur J Pharmacol; 2011 Jan; 650(2-3):496-500. PubMed ID: 20970418
[TBL] [Abstract][Full Text] [Related]
18. A new Co(III)-hypocrellin B complex with enhanced photonuclease activity.
Sun Y; Hou YJ; Zhou QX; Chen JR; Zhang BW; Wang XS
J Inorg Biochem; 2011 Jul; 105(7):978-84. PubMed ID: 21561592
[TBL] [Abstract][Full Text] [Related]
19. Hypocrellin Derivative-Loaded Calcium Phosphate Nanorods as NIR Light-Triggered Phototheranostic Agents with Enhanced Tumor Accumulation for Cancer Therapy.
Wang H; Jia Q; Liu W; Nan F; Zheng X; Ding Y; Ren H; Wu J; Ge J
ChemMedChem; 2020 Jan; 15(2):177-181. PubMed ID: 31755659
[TBL] [Abstract][Full Text] [Related]
20. In vitro study of the photocytotoxicity of bathochromically-shifted hypericin derivatives.
Roelants M; Lackner B; Waser M; Falk H; Agostinis P; Van Poppel H; de Witte PA
Photochem Photobiol Sci; 2009 Jun; 8(6):822-9. PubMed ID: 19492110
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
